Brief: Oncology Institute Inc Partners With Blue Note Therapeutics To Provide Digital Therapeutic For Treating Cancer-Related Anxiety And Depression Symptoms
22/08/2022 13:12
Aug 22 (Reuters) - Oncology Institute Inc TOI.O :
* ONCOLOGY INSTITUTE INC-ONCOLOGY INSTITUTE PARTNERS WITH
BLUE
NOTE THERAPEUTICS TO PROVIDE A DIGITAL THERAPEUTIC FOR TREATING
CANCER-RELATED ANXIETY AND DEPRESSION SYMPTOMS
Source text for Eikon: ID:nGNX4Yg4d7
Further company coverage: TOI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million